Core Viewpoint - LiuZhou Two-Sided Needle Co., Ltd. has successfully registered its Academy of Sciences Workstation, aiming to enhance technological innovation and collaboration in the oral health sector [1][2]. Group 1: Company Announcement - The company received notification from the Guangxi Science and Technology Department regarding the approval of its Academy of Sciences Workstation for the year 2025 [1]. - The establishment of the workstation is part of a collaboration agreement signed with Academician Du Ruxu and Guangdong Jianqi Biological Technology Co., Ltd. [2]. Group 2: Collaboration Details - The collaboration involves joint research on key technologies related to oral disease prevention and health services, focusing on the development of artificial intelligence applications in oral care products [2]. - Du Ruxu, a prominent academician, holds multiple prestigious titles and is recognized as a national high-level talent, contributing significant expertise to the partnership [2]. Group 3: Financial Impact - The establishment of the Academy of Sciences Workstation is not expected to have a significant short-term impact on the company's financial status or operational performance [2].

Group 1 - The stock price of Two Sides Needle is reported at 5.74 yuan as of August 14, 2025, with a decline of 2.05% compared to the previous trading day [1] - The trading volume on the same day was 125,924 hands, with a transaction amount of 0.73 billion yuan [1] - Two Sides Needle operates in the beauty and personal care industry, focusing on oral care and personal care sectors [1] Group 2 - The company has recently been approved to establish an academician workstation in collaboration with Academician Du Ruxu and Guangdong Jianchi Biotechnology to conduct key technology research in the field of oral health [1] - The workstation has been filed with the Guangxi Science and Technology Department, and the collaboration will focus on research related to the prevention of oral diseases and health services [1] - However, this project is not expected to have a significant impact on the company's financials in the short term [1] Group 3 - In the first quarter of 2025, the company achieved a revenue of 2.40 billion yuan, but reported a net loss of 14.17 million yuan [1] - On August 14, 2025, the net inflow of main funds was 1.52 million yuan, but there was an overall net outflow of 15.61 million yuan in the past five days [1]

证券代码：600249 证券简称：两面针 公告编号：临 2025-031 特此公告。 柳州两面针股份有限公司董事会 2025 年 8 月 15 日 柳州两面针股份有限公司（以下简称"公司"）于近日收到广西科 学技术厅《关于 2025 年度第二批广西院士工作站备案名单的通知》， 公司建设院士工作站通过备案。 为充分发挥院士专家对科技创新发展的推动作用，搭建科技合作 和交流平台，提升创新能力。公司、杜如虚院士、广东健齿生物科技 有限公司（以下简称"健齿生物"）三方签署了《共同组建院士工作站 合作协议》。杜如虚院士为中国香港籍，博士、教授、加拿大工程院 院士，国际制造工程师学会院士，美国机械工程师学会院士，国家级 高层次人才，广东省科技领军人才，香港工程师协会院士，健齿生物 首席科学家。健齿生物是具有国家二类、三类医辽器械资质的省级专 精特新企业、高新技术企业，同时拥有牙种植体和个性化基台三类注 册证的企业。三方以共同组建的院士工作站为基础，围绕口腔行业发 展需要及国内外技术发展趋势，共同研究口腔疾病预防、口腔健康服 务等方面的关键技术。探索应用人工智能技术研发口腔护理用品，培 养科技创新人才，提高企业的自主创新能 ...

Group 1 - The company, Two Sides Needle, has received notification from the Guangxi Science and Technology Department that its establishment of an academician workstation has been approved [1] - The company, Academician Du Ruxu, and Guangdong Jianchi Biotechnology Co., Ltd. have signed a cooperation agreement to jointly establish the academician workstation [1] - The collaboration will focus on key technologies related to the prevention of oral diseases and oral health services, addressing the needs of the oral industry and trends in domestic and international technology development [1]

格隆汇8月14日丨两面针(600249.SH)公布，公司于近日收到广西科学技术厅《关于2025年度第二批广西 院士工作站备案名单的通知》，公司建设院士工作站通过备案。 为充分发挥院士专家对科技创新发展的推动作用，搭建科技合作和交流平台，提升创新能力。公司、杜 如虚院士、广东健齿生物科技有限公司（以下简称"健齿生物"）三方签署了《共同组建院士工作站合作 协议》。杜如虚院士为中国香港籍，博士、教授、加拿大工程院院士，国际制造工程师学会院士，美国 机械工程师学会院士，国家级高层次人才，广东省科技领军人才，香港工程师协会院士，健齿生物首席 科学家。健齿生物是具有国家二类、三类医辽器械资质的省级专精特新企业、高新技术企业，同时拥有 牙种植体和个性化基台三类注册证的企业。三方以共同组建的院士工作站为基础，围绕口腔行业发展需 要及国内外技术发展趋势，共同研究口腔疾病预防、口腔健康服务等方面的关键技术。探索应用人工智 能技术研发口腔护理用品，培养科技创新人才，提高企业的自主创新能力和核心竞争力。 ...

两面针公告，公司于近日收到广西科学技术厅《关于2025年度第二批广西院士工作站备案名单的通 知》，公司建设院士工作站通过备案。为充分发挥院士专家对科技创新发展的推动作用，搭建科技合作 和交流平台，提升创新能力，公司、杜如虚院士、广东健齿生物科技有限公司三方签署了《共同组建院 士工作站合作协议》。杜如虚院士为中国香港籍，博士、教授、加拿大工程院院士，国际制造工程师学 会院士，美国机械工程师学会院士，国家级高层次人才，广东省科技领军人才，香港工程师协会院士， 健齿生物首席科学家。健齿生物是具有国家二类、三类医疗器械资质的省级专精特新企业、高新技术企 业，同时拥有牙种植体和个性化基台三类注册证的企业。 ...

Market Overview - The personal care products sector experienced a decline of 0.25% on August 14, with Jieya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3666.44, down 0.46%, while the Shenzhen Component Index closed at 11451.43, down 0.87% [1] Stock Performance - Notable gainers included: - Ziya Co., Ltd. (003006) with a closing price of 29.55, up 1.90% [1] - Haoyue Nursing (605009) at 41.00, up 1.89% [1] - Runben Co., Ltd. (603193) at 31.99, up 1.56% [1] - Significant decliners included: - Jieya Co., Ltd. (301108) at 25.99, down 2.91% [2] - Yiyi Co., Ltd. (001206) at 25.60, down 2.66% [2] - Dengkang Oral (001328) at 42.96, down 2.63% [2] Capital Flow - The personal care products sector saw a net outflow of 33.13 million yuan from institutional investors, while retail investors contributed a net inflow of 5.13 million yuan [2] - The capital flow details indicate: - Runben Co., Ltd. had a net inflow of 25.75 million yuan from institutional investors [3] - Jieya Co., Ltd. experienced a net outflow of 2.27 million yuan from institutional investors [3] - Retail investors showed a net inflow of 1.75 million yuan into Baijia Co., Ltd. [3]

Market Overview - The personal care products sector increased by 1.08% on August 13, with Baiya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Stock Performance - Baiya Co., Ltd. (stock code: 003006) closed at 29.00, with a rise of 6.42% and a trading volume of 106,100 shares, amounting to a transaction value of 305 million yuan [1] - Other notable stocks include: - Runben Co., Ltd. (603193) closed at 31.50, up 0.57% [1] - Stable Medical (300888) closed at 41.08, up 0.37% [1] - Haoyue Nursing (605009) closed at 40.24, up 0.25% [1] - Reliable Co., Ltd. (301009) remained unchanged at 14.88 [1] - Zhongshun Jierou (002511) closed at 8.17, down 0.37% [1] Capital Flow - The personal care products sector experienced a net outflow of 136 million yuan from institutional investors, while retail investors saw a net inflow of 176 million yuan [2][3] - The capital flow for key stocks includes: - Stable Medical: net outflow of 34.40 million yuan from institutional investors [3] - Reliable Co., Ltd.: net outflow of 20.07 million yuan from institutional investors [3] - Runben Co., Ltd.: net outflow of 6.64 million yuan from institutional investors [3]

Trading Information Summary - On August 11, 2025, the stock of Two-Mouth Needle (600249) closed at 5.91 yuan, an increase of 0.51%, with a turnover rate of 1.85% and a trading volume of 101,500 shares, resulting in a transaction amount of 59.9476 million yuan [1]. - On the same day, the capital flow showed a net outflow of 159.64 thousand yuan from main funds, accounting for 2.66% of the total transaction amount, while retail investors had a net inflow of 210.09 thousand yuan, representing 3.5% of the total transaction amount [1][3]. Company Announcement Summary - Two-Mouth Needle Co., Ltd. announced its 2024 annual equity distribution plan, stating that a cash dividend of 0.03 yuan per share (before tax) will be distributed [1]. - The key dates for the dividend distribution are as follows: the A-share registration date is August 15, 2025, and the ex-dividend date and cash dividend payment date are both set for August 18, 2025 [1]. - The total cash dividend to be distributed amounts to 16.5 million yuan, based on the company's total share capital of 550 million shares [1]. - Tax implications for different shareholders include: - For individual shareholders and securities investment funds, the actual cash dividend received will be subject to tax based on the holding period. - For Qualified Foreign Institutional Investors (QFII), a 10% tax will be withheld, resulting in a net dividend of 0.027 yuan per share. - For Hong Kong investors holding shares through "Shanghai-Hong Kong Stock Connect," the same 10% tax applies, leading to a net dividend of 0.027 yuan per share [1].

Group 1 - The stock price of the company, Two-faced Needle, closed at 5.91 yuan on August 11, 2025, with an increase of 0.03 yuan, representing a rise of 0.51% compared to the previous trading day [1] - The trading volume on that day was 101,475 hands, with a transaction amount reaching 0.6 billion yuan [1] - The company is primarily engaged in the research, production, and sales of daily chemical products, including toothpaste, toothbrushes, and cleaning products, and is categorized within the beauty and personal care industry [1] Group 2 - On the evening of August 11, the company announced its 2024 annual equity distribution plan, proposing a cash dividend of 0.3 yuan (tax included) for every 10 shares to all shareholders [1] - The record date for the dividend is set for August 15, 2025, and the ex-dividend date is August 18, 2025 [1] - On August 11, the net outflow of main funds was 1.5964 million yuan, with a cumulative net outflow of 10.3478 million yuan over the past five trading days [1]